Litcius/Paper detail

Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials

Giovanni Maria Iannantuono, Elias Chandran, Charalampos S. Floudas, Hyoyoung Choo‐Wosoba, Gisela Butera, Mario Roselli, James L. Gulley, Fatima Karzai

2023Cancer Treatment Reviews36 citationsDOIOpen Access PDF

Topics & Concepts

MedicineOncologyProstate cancerInternal medicineClinical trialCochrane LibraryDiscontinuationAdverse effectCancerMeta-analysisProstate Cancer Treatment and ResearchPARP inhibition in cancer therapyProstate Cancer Diagnosis and Treatment
Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials | Litcius